We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Virus-related reagents.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Virus-related reagents - List of Manufacturers, Suppliers, Companies and Products

Virus-related reagents Product List

1～2 item / All 2 items

Displayed results
Coronavirus Products

Coronavirus Products

Assay development or research/analytical investigation! QC for molecular biological tests and antigen tests.

Bairokquest Inc. provides a wide range of services to all researchers active at the forefront of life sciences. Coronaviruses are common worldwide and are part of a large family of viruses that can cause diseases ranging from the common cold to Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome. We provide developers and laboratories with safe-to-use external quality control/panels for assay development or research and analytical studies. [Features] ■ NATtrol molecular controls are non-infectious, ready-to-use whole organisms designed to evaluate the performance of molecular tests. ■ Can be used for assay validation, training of testing personnel, and monitoring lot performance of assay kits. ■ Ultraviolet-inactivated virus culture media is designed for analytical testing using antigens. *For more details, please refer to the PDF materials or feel free to contact us.

  • Culture water
  • Other cell research

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Influenza virus-related reagents

Influenza virus-related reagents

Sino Biological's influenza virus research reagents

The influenza virus is an RNA virus that causes acute respiratory diseases and outbreaks in human populations due to its strong infectivity. According to the WHO, influenza results in approximately 1 billion infections and about 290,000 to 650,000 deaths worldwide each year. Vaccination is the most effective strategy to prevent influenza virus infection and its severe complications. However, the influenza virus is prone to mutation, and the circulating strains vary from year to year. Each year, vaccine manufacturers develop and produce influenza vaccines based on the strains recommended by the WHO. Our company provides comprehensive influenza vaccine development services and production solutions to vaccine manufacturers. We offer a wide range of research reagents for influenza viruses, including influenza vaccine antigens, antibody pairs, neutralizing antibodies, and kits. Additionally, we provide high-quality technical services such as kit development, antigen expression, and antibody development. These products and services are suitable for various vaccine development scenarios, including screening of vaccine candidate strains, preparation of virus seed batches, evaluation of vaccine safety and immunogenicity, and assessment of vaccine protective effects.

  • Other research reagents

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.